RCS Capital (NYSE: RCAP) 47.0% LOWER; provided the following update as the Company continues to execute on its plan to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

3Q EPS Miss Driven by Decline in Revenue; Roth Capital Reiterates Buy on Iconix Brand Group (ICON) November 11, 2015 7:47 AM Cowen Cuts Price Target on Aegerion Pharma (AEGR) Following 3Q Results November 10, 2015 8:35 AM Leerink Partners Reiterates Outperform on Calithera Biosciences (CALA) Following 3Q November 10, 2015 7:00 AM Loxo Oncology (LOXO) Releases LOXO-101 Data; Oppenheimer Raises Price Target to $30 November 9, 2015 3:45 PM